SLP vs WST · rev $79.2M vs P/E 35, rev $1.72B
Simulations Plus Inc (SLP) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Simulations Plus Inc (SLP) is a health information services company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported SLP revenue for 2025-08-31 was $79.2M. Net income was -$64.7M. SLP currently screens at market cap $368.8M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
SLP currently screens at market cap $368.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the SLP and WST stock pages for the full models.
Not investment advice.